Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 282

1.

Receptor binding, fusion inhibition, and induction of cross-reactive neutralizing antibodies by a soluble G glycoprotein of Hendra virus.

Bossart KN, Crameri G, Dimitrov AS, Mungall BA, Feng YR, Patch JR, Choudhary A, Wang LF, Eaton BT, Broder CC.

J Virol. 2005 Jun;79(11):6690-702.

2.

Potent neutralization of Hendra and Nipah viruses by human monoclonal antibodies.

Zhu Z, Dimitrov AS, Bossart KN, Crameri G, Bishop KA, Choudhry V, Mungall BA, Feng YR, Choudhary A, Zhang MY, Feng Y, Wang LF, Xiao X, Eaton BT, Broder CC, Dimitrov DS.

J Virol. 2006 Jan;80(2):891-9.

3.

Exceptionally potent cross-reactive neutralization of Nipah and Hendra viruses by a human monoclonal antibody.

Zhu Z, Bossart KN, Bishop KA, Crameri G, Dimitrov AS, McEachern JA, Feng Y, Middleton D, Wang LF, Broder CC, Dimitrov DS.

J Infect Dis. 2008 Mar 15;197(6):846-53. doi: 10.1086/528801.

PMID:
18271743
4.

Novel Functions of Hendra Virus G N-Glycans and Comparisons to Nipah Virus.

Bradel-Tretheway BG, Liu Q, Stone JA, McInally S, Aguilar HC.

J Virol. 2015 Jul;89(14):7235-47. doi: 10.1128/JVI.00773-15. Epub 2015 May 6.

5.

Neutralization assays for differential henipavirus serology using Bio-Plex protein array systems.

Bossart KN, McEachern JA, Hickey AC, Choudhry V, Dimitrov DS, Eaton BT, Wang LF.

J Virol Methods. 2007 Jun;142(1-2):29-40. Epub 2007 Feb 9.

PMID:
17292974
6.

Ephrin-B2 ligand is a functional receptor for Hendra virus and Nipah virus.

Bonaparte MI, Dimitrov AS, Bossart KN, Crameri G, Mungall BA, Bishop KA, Choudhry V, Dimitrov DS, Wang LF, Eaton BT, Broder CC.

Proc Natl Acad Sci U S A. 2005 Jul 26;102(30):10652-7. Epub 2005 Jul 5.

7.

Membrane fusion tropism and heterotypic functional activities of the Nipah virus and Hendra virus envelope glycoproteins.

Bossart KN, Wang LF, Flora MN, Chua KB, Lam SK, Eaton BT, Broder CC.

J Virol. 2002 Nov;76(22):11186-98.

8.

Efficient reverse genetics reveals genetic determinants of budding and fusogenic differences between Nipah and Hendra viruses and enables real-time monitoring of viral spread in small animal models of henipavirus infection.

Yun T, Park A, Hill TE, Pernet O, Beaty SM, Juelich TL, Smith JK, Zhang L, Wang YE, Vigant F, Gao J, Wu P, Lee B, Freiberg AN.

J Virol. 2015 Jan 15;89(2):1242-53. doi: 10.1128/JVI.02583-14. Epub 2014 Nov 12.

9.

Multiple Strategies Reveal a Bidentate Interaction between the Nipah Virus Attachment and Fusion Glycoproteins.

Stone JA, Vemulapati BM, Bradel-Tretheway B, Aguilar HC.

J Virol. 2016 Nov 14;90(23):10762-10773. Print 2016 Dec 1.

10.

Molecular determinants of antiviral potency of paramyxovirus entry inhibitors.

Porotto M, Carta P, Deng Y, Kellogg GE, Whitt M, Lu M, Mungall BA, Moscona A.

J Virol. 2007 Oct;81(19):10567-74. Epub 2007 Jul 25.

12.

Single amino acid changes in the Nipah and Hendra virus attachment glycoproteins distinguish ephrinB2 from ephrinB3 usage.

Negrete OA, Chu D, Aguilar HC, Lee B.

J Virol. 2007 Oct;81(19):10804-14. Epub 2007 Jul 25.

13.

Expression, characterisation and antigenicity of a truncated Hendra virus attachment protein expressed in the protozoan host Leishmania tarentolae.

Fischer K, dos Reis VP, Finke S, Sauerhering L, Stroh E, Karger A, Maisner A, Groschup MH, Diederich S, Balkema-Buschmann A.

J Virol Methods. 2016 Feb;228:48-54. doi: 10.1016/j.jviromet.2015.11.006. Epub 2015 Nov 29.

14.

A functional henipavirus envelope glycoprotein pseudotyped lentivirus assay system.

Khetawat D, Broder CC.

Virol J. 2010 Nov 12;7:312. doi: 10.1186/1743-422X-7-312.

15.

Rhabdovirus-based vaccine platforms against henipaviruses.

Kurup D, Wirblich C, Feldmann H, Marzi A, Schnell MJ.

J Virol. 2015 Jan;89(1):144-54. doi: 10.1128/JVI.02308-14. Epub 2014 Oct 15.

16.

Inhibition of henipavirus infection by Nipah virus attachment glycoprotein occurs without cell-surface downregulation of ephrin-B2 or ephrin-B3.

Sawatsky B, Grolla A, Kuzenko N, Weingartl H, Czub M.

J Gen Virol. 2007 Feb;88(Pt 2):582-91.

PMID:
17251577
17.

Functional expression and membrane fusion tropism of the envelope glycoproteins of Hendra virus.

Bossart KN, Wang LF, Eaton BT, Broder CC.

Virology. 2001 Nov 10;290(1):121-35.

18.

N-glycans on Nipah virus fusion protein protect against neutralization but reduce membrane fusion and viral entry.

Aguilar HC, Matreyek KA, Filone CM, Hashimi ST, Levroney EL, Negrete OA, Bertolotti-Ciarlet A, Choi DY, McHardy I, Fulcher JA, Su SV, Wolf MC, Kohatsu L, Baum LG, Lee B.

J Virol. 2006 May;80(10):4878-89.

19.

Crystal structure of the Hendra virus attachment G glycoprotein bound to a potent cross-reactive neutralizing human monoclonal antibody.

Xu K, Rockx B, Xie Y, DeBuysscher BL, Fusco DL, Zhu Z, Chan YP, Xu Y, Luu T, Cer RZ, Feldmann H, Mokashi V, Dimitrov DS, Bishop-Lilly KA, Broder CC, Nikolov DB.

PLoS Pathog. 2013;9(10):e1003684. doi: 10.1371/journal.ppat.1003684. Epub 2013 Oct 10.

20.

Envelope-receptor interactions in Nipah virus pathobiology.

Lee B.

Ann N Y Acad Sci. 2007 Apr;1102:51-65. Review.

PMID:
17470911

Supplemental Content

Support Center